The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

MDS as an Immunoresponsive Disease

Marco Davila, MD, PhD
Published Online: 9:12 PM, Mon September 19, 2016

Marco Davila, MD, PhD, medical oncologist, Moffitt Cancer Center, discusses MDS as an immunoresponsive disease and applying immunotherapies to MDS.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.